Atlas Trials

A Long-Term Study in Schizophrenia

Clinical trial NCT01487083 · TERMINATED

Trial details

NCT number
NCT01487083
Sponsor
Eli Lilly and Company
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-12-01
Primary completion
2012-10-01
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.